Category Events

Merck to Acquire Sentinel

Merck Animal Health has reached an agreement with Virbac to acquire the U.S. rights to Sentinel Flavor Tabs (milbemycin oxime/lufenuron) and Sentinel Spectrum Chews (milbemycin oxime/lufenuron/praziquantel) for approximately $400 million, according to a company press release.

ProHeart® 12 Approved

The U.S. Food and Drug Administration (FDA) has approved ProHeart® 12 (moxidectin), the new, first-ever once-yearly injection to prevent heartworm disease (caused by Dirofilaria immitis) in dogs 12 months of age and older. Its unique formulation of moxidectin microspheres provides…